Lally, J. S. V., Jain, S. S., Han, X. X., Snook, L. A., Glatz, J. F. C., Luiken, J. J. F. P., McFarlan, J., Holloway, G. P., & Bonen, A. (2012). Caffeine-stimulated fatty acid oxidation is blunted in CD36 null mice. Acta Physiologica, 205(1), 71-81. https://doi.org/10.1111/j.1748-1716.2012.02396.x

Papageorgiou, A.-P., & Heymans, S. (2012). Interactions between the extracellular matrix and inflammation during viral myocarditis. Immunobiology, 217(5), 503-510. https://doi.org/10.1016/j.imbio.2011.07.011

Donners, M. M. P. C., Wolfs, I. M. J., Stoger, L. J., van der Vorst, E. P. C., Pottgens, C. C. H., Heymans, S., Schroen, B., Gijbels, M. J. J., & de Winther, M. P. J. (2012). Hematopoietic miR155 Deficiency Enhances Atherosclerosis and Decreases Plaque Stability in Hyperlipidemic Mice. PLOS ONE, 7(4), Article e35877. https://doi.org/10.1371/journal.pone.0035877

Papageorgiou, A.-P., Swinnen, M., Vanhoutte, D., VandenDriessche, T., Chuah, M., Lindner, D., Verhesen, W., de Vries, B., D'hooge, J., Lutgens, E., Westermann, D., Carmeliet, P., & Heymans, S. (2012). Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory T-cells. Cardiovascular Research, 94(1), 115-124. https://doi.org/10.1093/cvr/cvs077

Jin, Y., Kuznetsova, T., Thijs, L., Schmitz, B., Liu, Y., Asayama, K., Brand, S.-M., Heymans, S., Brand, E., Fagard, R., & Staessen, J. A. (2012). Association of Left Ventricular Mass With the AGTR1 A1166C Polymorphism. American Journal of Hypertension, 25(4), 472-478. https://doi.org/10.1038/ajh.2011.244

Martins, P. A. D. C., & De Windt, L. J. (2012). MicroRNAs in control of cardiac hypertrophy. Cardiovascular Research, 93(4), 563-572. https://doi.org/10.1093/cvr/cvs013

Schroen, B., & Heymans, S. (2012). Small but smart-microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing. Cardiovascular Research, 93(4), 605-613. https://doi.org/10.1093/cvr/cvr268

Muzzarelli, S., Maeder, M. T., Toggweiler, S., Rickli, H., Nietlispach, F., Julius, B., Burkard, T., Pfisterer, M. E., & Brunner-La Rocca, H.-P. (2012). Frequency and Predictors of Hyperkalemia in Patients >= 60 Years of Age With Heart Failure Undergoing Intense Medical Therapy. American Journal of Cardiology, 109(5), 693-698. https://doi.org/10.1016/j.amjcard.2011.10.027

Burkard, T., Kaiser, C. A., Brunner-La Rocca, H., Osswald, S., Pfisterer, M. E., & Jeger, R. V. (2012). Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial. Journal of Internal Medicine, 271(3), 257-263. https://doi.org/10.1111/j.1365-2796.2011.02423.x

Maeder, M. T., Rickli, H., Pfisterer, M. E., Muzzarelli, S., Ammann, P., Fehr, T., Hack, D., Weilenmann, D., Dieterle, T., Kiencke, S., Estlinbaum, W., & Brunner-La Rocca, H.-P. (2012). Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy. American Heart Journal, 163(3), 407-U353. https://doi.org/10.1016/j.ahj.2011.12.003

Devaux, Y., Vausort, M., Goretti, E., Nazarov, P. V., Azuaje, F., Gilson, G., Corsten, M. F., Schroen, B., Lair, M.-L., Heymans, S., & Wagner, D. R. (2012). Use of Circulating MicroRNAs to Diagnose Acute Myocardial Infarction. Clinical Chemistry, 58(3), 559-567. https://doi.org/10.1373/clinchem.2011.173823

Zellweger, M. J., Kaiser, C. A., Jeger, R. V., Brunner-La Rocca, H.-P., Buser, P. T., Bader, F., Mueller-Brand, J., & Pfisterer, M. E. (2012). Coronary Artery Disease Progression Late After Successful Stent Implantation. Journal of the American College of Cardiology, 59(9), 793-799. https://doi.org/10.1016/j.jacc.2011.11.024

Dirkx, E., Schwenk, R. W., Coumans, W. A., Hoebers, N., Angin, Y., Viollet, B., Bonen, A., van Eys, G. J. J. M., Glatz, J. F. C., & Luiken, J. J. F. P. (2012). Protein Kinase D1 Is Essential for Contraction-induced Glucose Uptake but Is Not Involved in Fatty Acid Uptake into Cardiomyocytes. Journal of Biological Chemistry, 287(8), 5871-5881. https://doi.org/10.1074/jbc.M111.281881

Daskalopoulos, E. P., Janssen, B. J. A., & Blankesteijn, W. M. (2012). Myofibroblasts in the Infarct Area: Concepts and Challenges. Microscopy and Microanalysis, 18(1), 35-49. https://doi.org/10.1017/S143192761101227X

Heijman, J., Spätjens, R. L. H., Seyen, S. R. M., Lentink, V., Kuijpers, H. J. H., Boulet, I. R., de Windt, L. J., David, M., & Volders, P. G. A. (2012). Dominant-Negative Control of cAMP-Dependent I-Ks Upregulation in Human Long-QT Syndrome Type 1. Circulation Research, 110(2), 211–219. https://doi.org/10.1161/CIRCRESAHA.111.249482

Octavia, Y., Rocca, H. P. B.-L., & Moens, A. L. (2012). NADPH oxidase-dependent oxidative stress in the failing heart: From pathogenic roles to therapeutic approach. Free Radical Biology and Medicine, 52(2), 291-297. https://doi.org/10.1016/j.freeradbiomed.2011.10.482

van Wijk, S., Jacobs, L., Eurlings, L. W., van Kimmenade, R., Lemmers, R., Broos, P., Bekers, O., Prins, M. H., Crijns, H. J., Pinto, Y. M., van Dieijen-Visser, M. P., & Brunner-La Rocca, H. P. (2012). Troponin T Measurements by High-Sensitivity vs Conventional Assays for Risk Stratification in Acute Dyspnea. Clinical Chemistry, 58(1), 284-292. https://doi.org/10.1373/clinchem.2011.175976

Gladka, M. M., Martins, P. A. D. C., & de Windt, L. J. (2012). Small changes can make a big difference - MicroRNA regulation of cardiac hypertrophy. Journal of Molecular and Cellular Cardiology, 52(1), 74-82. https://doi.org/10.1016/j.yjmcc.2011.09.015

ter Horst, P., Smits, J. F. M., & Blankesteijn, W. M. (2012). The Wnt/Frizzled pathway as a therapeutic target for cardiac hypertrophy: where do we stand. Acta Physiologica, 204(1), 110-117. https://doi.org/10.1111/j.1748-1716.2011.02309.x

Halbach, N. S. J., Smeets, E. E. J., Bierau, J., Keularts, I. M. L. W., Plasqui, G., Julu, P. O. O., Engerström, I. W., Bakker, J. A., & Curfs, L. M. G. (2012). Altered carbon dioxide metabolism and creatine abnormalities in rett syndrome. JIMD reports, 3, 117-24. https://doi.org/10.1007/8904_2011_76

Nabben, M., Hoeks, J., Kornips, C. F. P., Van Beurden, D., Briedé, J. J., Hesselink, M. K. C., Glatz, J. F., & Schrauwen, P. (2011). Significance of uncoupling protein 3 in mitochondrial function upon mid- and long-term dietary high-fat exposure. Febs Letters, 585(24), 4010-4017. https://doi.org/10.1016/j.febslet.2011.11.012

Bartelds, B., Borgdorff, M. A., Smit-van Oosten, A., Takens, J., Boersma, B., Nederhoff, M. G., Elzenga, N. J., van Gilst, W. H., De Windt, L. J., & Berger, R. M. F. (2011). Differential responses of the right ventricle to abnormal loading conditions in mice: pressure vs. volume load. European journal of heart failure, 13(12), 1275-1282. https://doi.org/10.1093/eurjhf/hfr134

He, B. J., Joiner, M. A., Singh, M. V., Luczak, E. D., Swaminathan, P. D., Koval, O. M., Kutschke, W., Allamargot, C., Yang, J., Guan, X., Zimmerman, K., Grumbach, I. M., Weiss, R. M., Spitz, D. R., Sigmund, C. D., Blankesteijn, W. M., Heymans, S., Mohler, P. J., & Anderson, M. E. (2011). Oxidation of CaMKII determines the cardiotoxic effects of aldosterone. Nature Medicine, 17(12), 1610-U125. https://doi.org/10.1038/nm.2506

Al-Roubaie, S., Jahnsen, E. D., Mohammed, M., Henderson-Toth, C., & Jones, E. A. V. (2011). Rheology of embryonic avian blood. American Journal of Physiology-heart and Circulatory Physiology, 301(6), H2473-81. https://doi.org/10.1152/ajpheart.00475.2011

Jones, E. A. V. (2011). The initiation of blood flow and flow induced events in early vascular development. Seminars in Cell & Developmental Biology, 22(9), 1028-35. https://doi.org/10.1016/j.semcdb.2011.09.020

Armand, A.-S., Laziz, I., Djeghloul, D., Lecolle, S., Bertrand, A. T., Biondi, O., De Windt, L. J., & Chanoine, C. (2011). Apoptosis-Inducing Factor Regulates Skeletal Muscle Progenitor Cell Number and Muscle Phenotype. PLOS ONE, 6(11), 15. https://doi.org/10.1371/journal.pone.0027283

Dirkx, E., Schwenk, R. W., Glatz, J. F. C., Luiken, J. J. F. P., & van Eys, G. J. J. M. (2011). High fat diet induced diabetic cardiomyopathy. Prostaglandins Leukotrienes and Essential Fatty Acids, 85(5), 219-225. https://doi.org/10.1016/j.plefa.2011.04.018

Laeremans, H., Hackeng, T. M., van Zandvoort, M. A. M. J., Thijssen, V. L. J. L., Janssen, B. J. A., Ottenheijm, H. C. J., Smits, J. F. M., & Blankesteijn, W. M. (2011). Blocking of Frizzled Signaling With a Homologous Peptide Fragment of Wnt3a/Wnt5a Reduces Infarct Expansion and Prevents the Development of Heart Failure After Myocardial Infarction. Circulation, 124(15), 1626-U107. https://doi.org/10.1161/CIRCULATIONAHA.110.976969

Steinbusch, L. K. M., Luiken, J. J. F. P., Vlasblom, R., Chabowski, A., Hoebers, N. T. H., Coumans, W. A., Vroegrijk, I. O. C. M., Voshol, P. J., Ouwens, D. M., Glatz, J. F. C., & Diamant, M. (2011). Absence of fatty acid transporter CD36 protects against Western-type diet-related cardiac dysfunction following pressure overload in mice. American Journal of Physiology : Endocrinology and Metabolism, 301(4), E618-E627. https://doi.org/10.1152/ajpendo.00106.2011

van Almen, G. C., Verhesen, W., van Leeuwen, R. E. W., van de Vrie, M., Eurlings, C., Schellings, M. W. M., Swinnen, M., Cleutjens, J. P. M., van Zandvoort, M. A. M. J., Heymans, S., & Schroen, B. (2011). MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell, 10(5), 769-779. https://doi.org/10.1111/j.1474-9726.2011.00714.x

van Almen, G. C., Swinnen, M., Carai, P., Verhesen, W., Cleutjens, J. P. M., D'hooge, J., Verheyen, F. K., Pinto, Y. M., Schroen, B., Carmeliet, P., & Heymans, S. (2011). Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy. Journal of Molecular and Cellular Cardiology, 51(3), 318-328. https://doi.org/10.1016/j.yjmcc.2011.05.010

Nergiz-Unal, R., Lamers, M. M. E., Van Kruchten, R., Luiken, J. J., Cosemans, J. M. E. M., Glatz, J. F. C., Kuijpers, M. J. E., & Heemskerk, J. W. M. (2011). Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low-density lipoprotein. Journal of Thrombosis and Haemostasis, 9(9), 1835-1846. https://doi.org/10.1111/j.1538-7836.2011.04416.x

Jones, E. A. V. (2011). Mechanical factors in the development of the vascular bed. Respiratory physiology & neurobiology, 178(1), 59-65. https://doi.org/10.1016/j.resp.2011.03.026

Olieslagers, S., Pardali, E., Tchaikovski, V., ten Dijke, P., & Waltenberger, J. (2011). TGF-beta 1/ALK5-induced monocyte migration involves PI3K and p38 pathways and is not negatively affected by diabetes mellitus. Cardiovascular Research, 91(3), 510-518. https://doi.org/10.1093/cvr/cvr100

Steinbusch, L. K. M., Schwenk, R. W., Ouwens, D. M., Diamant, M., Glatz, J. F. C., & Luiken, J. J. F. P. (2011). Subcellular trafficking of the substrate transporters GLUT4 and CD36 in cardiomyocytes. Cellular and Molecular Life Sciences, 68(15), 2525-2538. https://doi.org/10.1007/s00018-011-0690-x

Verkaar, F., van der Stelt, M., Blankesteijn, W. M., van der Doelen, A. A., & Zaman, G. J. R. (2011). Discovery of Novel Small Molecule Activators of beta-Catenin Signaling. PLOS ONE, 6(4), 7. https://doi.org/10.1371/journal.pone.0019185

Verkaar, F., van der Doelen, A. A., Smits, J. F. M., Blankesteijn, W. M., & Zaman, G. J. R. (2011). Inhibition of Wnt/beta-Catenin Signaling by p38 MAP Kinase Inhibitors Is Explained by Cross-Reactivity with Casein Kinase I delta/epsilon. Chemistry & Biology, 18(4), 485-494. https://doi.org/10.1016/j.chembiol.2011.01.015

el Azzouzi, H., Leptidis, S., Bourajjaj, M., Armand, A.-S., van der Nagel, R., van Bilsen, M., Martins, P. A. D. C., & De Windt, L. J. (2011). Peroxisome Proliferator-activated Receptor (PPAR) Gene Profiling Uncovers Insulin-like Growth Factor-1 as a PPAR alpha Target Gene in Cardioprotection. Journal of Biological Chemistry, 286(16), 14598-14607. https://doi.org/10.1074/jbc.M111.220525

Perino, A., Ghigo, A., Ferrero, E., More, F., Santulli, G., Baillie, G. S., Damilano, F., Dunlop, A. J., Pawson, C., Walser, R., Levi, R., Altruda, F., Silengo, L., Langeberg, L. K., Neubauer, G., Heymans, S., Lembo, G., Wymann, M. P., Wetzker, R., ... Hirsch, E. (2011). Integrating Cardiac PIP3 and cAMP Signaling through a PKA Anchoring Function of p110 gamma. Molecular Cell, 42(1), 84-95. https://doi.org/10.1016/j.molcel.2011.01.030

Mischke, K., Knackstedt, C., Fache, K., Reith, S., Rana, O., Saygili, E., Gemein, C., Becker, M., Marx, N., & Schauerte, P. (2011). Electrical remodelling in cardiac resynchronization therapy: decrease in intrinsic QRS duration. Acta Cardiologica, 66(2), 175-180. https://doi.org/10.1080/AC.66.2.2071248

Muzzarelli, S., Stricker, B. H., Pfister, O., Foglia, P., Moschovitis, G., Mombelli, G., & Brunner-La Rocca, H. (2011). Individual dosage of digoxin in patients with heart failure. QJM: An International Journal of Medicine, 104(4), 309-317. https://doi.org/10.1093/qjmed/hcq196

van de Vrie, M., Heymans, S., & Schroen, B. (2011). MicroRNA Involvement in Immune Activation During Heart Failure. Cardiovascular Drugs and Therapy, 25(2), 161-170. https://doi.org/10.1007/s10557-011-6291-y

Czepluch, F. S., Olieslagers, S., van Hulten, R., Voo, S. A., & Waltenberger, J. (2011). VEGF-A-induced chemotaxis of CD16+monocytes is decreased secondary to lower VEGFR-1 expression. Atherosclerosis, 215(2), 331-338. https://doi.org/10.1016/j.atherosclerosis.2011.01.004

Leventhal, M. E., Denhaerynck, K., Brunner-La Rocca, H.-P., Burnand, B., Conca, A., Bernasconi, A. T., Mahrer-Imhof, R., Froelicher, E. S., & De Geest, S. (2011). Swiss Interdisciplinary Management Programme for Heart Failure (SWIM-HF). Swiss Medical Weekly, 141, 10. https://doi.org/10.4414/smw.2011.13171

Bläuer, C., Mahrer-Imhof, R., Brunner-La Rocca, H., Mueller, C. P., Eze, G., Milbich, I., & Spirig, R. (2011). Development and Implementation of a multidisciplinary nurse-led educational programme for inpatients with heart failure: The Basel-HF-Programme: Entwicklung und Implementierung eines multidisziplinären pflegegeleiteten Programms zur stationären Betreuung von Patientinnen und Patienten mit Herzinsuffizienz: Das Basler HI-Programm. Pflege, 24(1), 29-41. https://doi.org/10.1024/1012-5302/a000089

Nabben, M., Shabalina, I. G., Kornips, C. F. P., Van Beurden, D., Cannon, B., Schrauwen, P., Nedergaard, J., & Hoeks, J. (2011). Uncoupled respiration, ROS production, acute lipotoxicity and oxidative damage in isolated skeletal muscle mitochondria from UCP3-ablated mice.Biochimica et Biophysica Acta-bioenergetics, 1807(9), 1095-1105. https://doi.org/10.1016/j.bbabio.2011.04.003

Eschenhagen, T., Force, T., Ewer, M. S., De Keulenaer, G. W., Suter, T. M., Anker, S. D., Avkiran, M., de Azambuja, E., Balligand, J. L., Brutsaert, D. L., Condorelli, G., Hansen, A., Heymans, S., Hill, J. A., Hirsch, E., Hilfiker-Kleiner, D., Janssens, S., de Jong, S., Neubauer, G., ... Shah, A. M. (2011). Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology. European journal of heart failure, 13(1), 1-10. https://doi.org/10.1093/eurjhf/hfq213

Holloway, G. P., Snook, L. A., Harris, R. J., Glatz, J. F. C., Luiken, J. J. F. P., & Bonen, A. (2011). In obese Zucker rats, lipids accumulate in the heart despite normal mitochondrial content, morphology and long-chain fatty acid oxidation. Journal of Physiology, 589(1), 169-180. https://doi.org/10.1113/jphysiol.2010.198663